The 2-Minute Rule for trastuzumab side effects
In July 2024, the CHMP adopted a positive view, recommending the granting of the internet marketing authorization for the medicinal product Tuznue, intended to the therapy of breast and gastric cancer.All drugs may perhaps lead to side effects. However, A lot of people haven't any side effects or only have minor side effects. Phone your health care